Discovery Capital Management’s Aehr Test Systems AEHR Stock Holding History

Discovery Capital Management’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-132,579	Closed	-$5.47M	–	41
2023 Q2	$5.47M	Sell	132,579 -13,797	-9%	-$453K	0.58%	46
2023 Q1	$4.54M	Buy	+146,376	New	+$4.72M	0.52%	40

Other funds holding AEHR

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Discovery Capital Management's AEHR Position: Q3 2023 in Review

Discovery Capital Management sold out of Aehr Test Systems (AEHR) in Q3 2023, closing a stake of 132,579 shares — an estimated $5.47M sold.

Discovery Capital Management first reported a position in AEHR in Q1 2023 and held it in 2 quarters. The position peaked at $5.47M in Q2 2023. 153 funds tracked by Wall St. Rank hold AEHR as of Q3 2023.

Discovery Capital Management reported no remaining Aehr Test Systems position as of Q3 2023 after selling out during the quarter.
Discovery Capital Management sold 132,579 Aehr Test Systems shares in Q3 2023, an estimated $5.47M.
Discovery Capital Management first reported a position in Aehr Test Systems in Q1 2023 and held it in 2 quarters.
Discovery Capital Management's Aehr Test Systems position peaked at $5.47M in Q2 2023.
153 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2023.

Based on Discovery Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.